iproniazid has been researched along with Rheumatic Diseases in 2 studies
Rheumatic Diseases: Disorders of connective tissue, especially the joints and related structures, characterized by inflammation, degeneration, or metabolic derangement.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| GAMARSKI, J | 1 |
| KRAMMER, F | 1 |
2 other studies available for iproniazid and Rheumatic Diseases
| Article | Year |
|---|---|
[2-(benzylcarbamyl)ethyl]-2-isonicotyl hydrazine (Nialamide) in subjects with different rheumatic and para-rheumatic diseases].
Topics: Female; Humans; Hydrazines; Iproniazid; Nialamide; Oxidoreductases; Parity; Rheumatic Diseases | 1961 |
[The significance of Niamide in the treatment of rheumatic diseases].
Topics: Humans; Iproniazid; Rheumatic Diseases | 1961 |